Clinical Trial Update: Polydiuretic Therapy for HFpEF, a Randomised Controlled Trial [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial of polydiuretic therapy for heart failure with preserved ejection fraction has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• Polydiuretic Therapy

Snippet

Sponsor: The George Institute | Conditions: Heart Failure With Preserved Ejection Fraction | Phase 4 | Status: TERMINATED